BioCentury
ARTICLE | Clinical News

Beposone: Phase II data

May 14, 2012 7:00 AM UTC

Top-line data from a double-blind, U.S. Phase II trial in about 600 patients aged 12 and older with allergic rhinitis due to Mountain Cedar pollen showed that twice-daily Beposone nasal spray signific...